348 studies found for:    HSV
Show Display Options
Rank Status Study
1 Recruiting Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
Conditions: Genital Herpes;   Herpes Simplex Virus;   Herpes Simplex Virus Vaccines;   HSV Vaccines;   Herpesvirus Vaccines
Intervention: Biological: HSV529
2 Recruiting HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
Condition: Non-CNS Solid Tumors
Intervention: Biological: HSV1716
3 Terminated A Study of HSV Testing Among Pregnant Women
Conditions: Herpes Simplex;   Pregnancy
Interventions: Behavioral: Safer-sex counseling;   Procedure: Type specific serologic HSV testing
4 Recruiting Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: HSV1716 Intra-pleural delivery
5 Recruiting Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture
Condition: Herpes Simplex Virus
Intervention: Device: Genexpert assay
6 Not yet recruiting A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)
Condition: Herpes Simplex Virus
Interventions: Drug: Novel Antiviral Drug;   Drug: Placebo
7 Completed Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant;   Biological: Herpes simplex candidate vaccine GSK208141- MPL-containing adjuvant
8 Completed Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141;   Biological: Herpes simplex virus containing gD-Alum
9 Active, not recruiting Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: Matrix-M2 Adjuvant;   Biological: GEN-003 Vaccine;   Drug: Placebo
10 Completed Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK208141;   Biological: Placebo injection
11 Completed Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
Condition: Prophylaxis for Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK 208141;   Biological: Placebo
12 Completed Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon
Conditions: HIV-1 and HSV-2 Coinfection;   HIV Infections
Intervention: Drug: Acyclovir
13 Recruiting Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
Conditions: Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma
Interventions: Biological: oncolytic HSV-1716;   Drug: dexamethasone;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
14 Active, not recruiting Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
Condition: Herpes Simplex Type II
Interventions: Drug: Tenofovir;   Drug: placebo gel;   Drug: tenofovir disoproxil fumarate (TDF);   Drug: placebo tablets
15 Completed HSV Oral Reactivation in Children
Conditions: HSV-1;   HIV
Intervention: Other: Underlying medical illness
16 Completed HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.
Conditions: HIV Infection;   Herpes Simplex;   Sexually Transmitted Diseases
Interventions: Drug: valacyclovir;   Drug: matching placebo
17 Completed
Has Results
Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
Condition: Oral Herpes Simplex
Interventions: Drug: BTL TML HSV;   Drug: Matching placebo
18 Completed
Has Results
HerpeVac Trial for Young Women
Condition: Herpes Simplex Infection
Interventions: Biological: HSV vaccine or SB208141, GSK Biologicals' glycoprotein D (gD)-Alum/3-deacylated form of Monophosphoryl Lipid A (MPL) candidate genital herpes vaccine;   Biological: Havrix™, GlaxoSmithKline (GSK) Biologicals' licensed Hepatitis A vaccine
19 Completed Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Conditions: HSV-2;   HIV;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
20 Completed HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant Women
Condition: Pregnancy
Intervention: Other: testing for HSV 1 and 2 IgG type specific antibosy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years